news

Our company website has been fully revised, and officially launched online on April 29, 2020.
MORE >>
Xgene Pharmaceutical Inc., a clinical development stage biopharmaceutical company, today announced that it recently held a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss the regulato...
MORE >>
Our company website has been fully established, and officially launched online on January 1, 2020.
MORE >>
Xgene Pharmaceutical has completed B Plus financing round successfully.The financing round was participated by Taiwania Captial, a famous venture capital company in Taiwan. Xgene plans to promote its pipeline product development through this ...
MORE >>
Xgene Pharmaceutical raised $20 million in series B financing round led by Ping An Ventures. Xgene's lead product, a combination of naproxen and pregabalin (Lyrica®) for chronic pain, is in Phase II trials in the US. Founded in 2015 Q4, X...
MORE >>